Prior to initiating a trial, what should be defined, established, and allocated?

Prepare for the ICH Good Clinical Practice (GCP) Exam for Certified Clinical Research Coordinator with engaging multiple-choice questions and detailed explanations. Elevate your understanding and expertise to excel in your certification exam!

Multiple Choice

Prior to initiating a trial, what should be defined, established, and allocated?

Explanation:
Before a trial begins, all trial-related duties and functions should be defined, established, and allocated. This means clearly identifying who is responsible for each task—such as conduct of the study, obtaining and documenting informed consent, safety reporting, source data verification, data entry, and protocol compliance—and recording those assignments in a Delegation of Authority Log or equivalent system. Establishing this allocation ensures accountability, proper supervision, and that every critical activity has a qualified person responsible for it, which supports participant safety and regulatory compliance. While a budget, the consent form, and a monitoring schedule are important components of trial planning and conduct, they do not address the fundamental need to map out who does what. The budget concerns resources needed, the consent form concerns participant authorization, and the monitoring schedule concerns oversight timing; none of these on their own guarantees that every trial-related function has a designated, competent owner before initiation.

Before a trial begins, all trial-related duties and functions should be defined, established, and allocated. This means clearly identifying who is responsible for each task—such as conduct of the study, obtaining and documenting informed consent, safety reporting, source data verification, data entry, and protocol compliance—and recording those assignments in a Delegation of Authority Log or equivalent system. Establishing this allocation ensures accountability, proper supervision, and that every critical activity has a qualified person responsible for it, which supports participant safety and regulatory compliance.

While a budget, the consent form, and a monitoring schedule are important components of trial planning and conduct, they do not address the fundamental need to map out who does what. The budget concerns resources needed, the consent form concerns participant authorization, and the monitoring schedule concerns oversight timing; none of these on their own guarantees that every trial-related function has a designated, competent owner before initiation.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy